Rapid HIV testing

References

• Rouzioux C, Costagliola D, Burgard M, et al. Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. Am J Epidemiol 1995; 142(12): 1330–7
   PubMed Web of Science ®Google Scholar
• Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 1994; 331 (18): 1173–80
   PubMed Web of Science ®Google Scholar
• loannidis JP, Abrams EJ, Ammann A, et al. Perinatal transmission of human immunodeficiency virus type 1 by pregnant women with RNA virus loads <1,000 copies/mL. J Infect Dis 2001; 183(4): 539–45
   Google Scholar
• Wade NA, Birkhead GS, Warren BL, et al. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998; 339(20): 1409–14
   PubMed Web of Science ®Google Scholar
• The International Perinatal HIV Group. The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1—a meta-analysis of 15 prospective cohort studies. N Engl J Med 1999; 340(13): 977–87
   PubMed Web of Science ®Google Scholar
• Bulterys M, Jamieson DJ, O'Sullivan MJ, et al; Mother-Infant Rapid Intervention at Delivery (MIRLAD) Study Group. Rapid HIV-1 testing during labor: a multicenter study. JAMA 2004; 292(2): 219–23
   Web of Science ®Google Scholar
• Peters V, Liu KL, Dominguez K, et al. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996–2000, pediatric spectrum of HIV disease cohort. Pediatrics 2003; 111(5 Pt 2): 1186–91
   PubMed Web of Science ®Google Scholar
• European Collaborative Study. Exposure to antiretroviral therapy in utero or early life: the health of uninfected children born to HIV-infected women. J Acquir Immune Defic Syndr 2003; 32(4): 380–7
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Rapid HIV-1 antibody testing during labor and delivery for women of unknown HIV status: a practical guide and model protocol. Atlanta: US Dept of Health and Human Services, Public Health Service, 2004. Available at: http://www.cdc.gov/hiv/rapid_testing/rt-labor&delivery.htm#introl. Accessed Nov 10, 2004
   Google Scholar
• Centers for Disease Control and Prevention. Updated US Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep 2001; 50(RR-11): 1–42
   Google Scholar
• Cardo DM, Culver DH, Ciesielski CA, et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997; 337(21): 1485–90
   PubMed Web of Science ®Google Scholar
• Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: final report from a longitudinal study. J Infect Dis 1994; 170(6): 1410–7
   PubMed Web of Science ®Google Scholar
• Kaltenborn JC, Price TG, Carrico R, et al. Emergency department management of occupational exposures: cost analysis of rapid HIV test. Infect Control Hosp Epidemiol 2001; 22(5): 289–93
   Google Scholar
• Bangsberg D, Goldschmidt RH. Postexposure prophylaxis for occupational exposure to HIV. JAMA 1999; 282(17): 1623–4
   Google Scholar
• Liddicoat RV, Horton NJ, Urban R, et al. Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med 2004; 19(4): 349–56
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Recommendations for HIV testing services for inpatients and outpatients in acute-care hospital settings. MMWR Morb Mortal Wkly Rep 1993; 42(8): 157–8
   PubMedGoogle Scholar
• Kelen GD, Hexter DA, Hansen KN, et al. Trends in human immunodeficiency virus (HIV) infection among a patient population of an innercity emergency department: implications for emergency department-based screening programs for HIV infection. Clin Infect Dis 1995; 21(4): 867–75
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Routinely recommended HIV testing at an urban urgent-care clinic—Atlanta, Georgia, 2000. MMWR Morb Mortal Wkly Rep 2001: 50(25): 538–41
   Google Scholar
• Kelen GD, Shahan JB, Quirin TC. Emergency department-based HIV screening and counseling: experience with rapid and standard serologic testing. Ann Emerg Med 1999; 33(2): 147–55
   PubMed Web of Science ®Google Scholar
• Kroc KA, Papiez GR, Parks DI, et al. Routine screening of emergency department (ED) patients using OraQuick HIV-1 antibody test. (Abstr) Presented at the 2003 National HIV Prevention Conference, Jul 27–30, 2003, Atlanta
   Google Scholar
• Centers for Disease Control and Prevention. HIV counseling and testing in publicly funded sites: annual report 1997 and 1998. Atlanta: US Dept of Health and Human Services, Public Health Service, 2001: 10. Available at: http://www.cdc.gov/hiv/pubs/cts98.pdf. Accessed Nov 11, 2004
   Google Scholar
• Stetler HC, Granade TC, Nunez CA, et al. Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS 1997; 11(3): 369–75
   Google Scholar
• Joint United Nations Programme on HIV/AIDS (UNAIDS)—WHO: Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997: 72(12): 81–7
   Google Scholar